Fujian Haixi Pharmaceuticals Co., Ltd. (HKG:2637)
136.50
+0.50 (0.37%)
At close: Feb 13, 2026
HKG:2637 Revenue
In the year 2024, Fujian Haixi Pharmaceuticals had annual revenue of 466.68M CNY with 47.39% growth.
Revenue
466.68M CNY
Revenue Growth
+47.39%
P/S Ratio
21.63
Revenue / Employee
2.85M CNY
Employees
164
Market Cap
10.74B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 466.68M | 150.05M | 47.39% |
| Dec 31, 2023 | 316.63M | 104.17M | 49.03% |
| Dec 31, 2022 | 212.47M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition